|
Dear
Colleagues,
I wish everyone of you happiness, peace and prosperity, for all time to come. I am very happy to present you with this issue of the APCRI Journal, Volume IX, issue 2. The Journal of any professional and scientific organization is the medium through which everyone can get relevant information about the academic and scientific activities of that organization. It is most essential for creating interest about the academic and scientific activities in that organization amongst its members. I hereby thank all the contributors for their articles. Without an abundant supply of articles, no editor can bring out a journal. I take this opportunity to once again request the scientific community for articles on Rabies and related topics for publication in the "APCRI Journal", in future. India is trying to start the usage of IDRV in a big way, throughout the country. Incidentally Thailand, Sri Lanka and the Philippines are the only three countries where IDRV is practiced on actual patients attending regular Anti Rabies Clinics. The experience gathered by the three countries has to be considered by the policy planners in India, if they desire to implement IDRV with minimum trouble and risk to all. I would like to inform that the Editorial has been written by the editor (that is me) only, and not by any committee or group, and is not necessarily the opinion of the general body or the executive committee of APCRI. I thank the corporate houses of Ranbaxy and Novartis Vaccines for their Advertisements. I also thank Dr. G.Sampath, President APCRI, Dr. D.H.Ashwathnarayana, Secretary General, APCRI, and Dr.H. S. Ravish, Treasurer APCRI for helping me to bring out this issue of the APCRI Journal. This issue of the APCRI Journal is a step in the endeavor of the APCRI to fight the menace of Rabies by increasing the awareness about Rabies in all sections of the society. Let us all commit ourselves for the elimination of human rabies from India.
31st
January, 2008
Dr. Amlan Goswami |